Limula's End-to-End Cell Processing Platform Enters Beta Testing

Limula's End-to-End Cell Processing Platform Enters Beta Testing

Rapid advances in cell therapy have resulted in complex processes. As they move toward the clinic, manufacturers are attempting to scale up or scale out the processes using legacy equipment that often was designed for other purposes. For manufacturers, this means transport cell cultures from instrument to instrument. Much of the work is still manual, which delays optimal timelines and comes with risks or contamination, cell stress, and cell loss…